Cleared Special

K241607 - MyoStrain (6.0) (FDA 510(k) Clearance)

Aug 2024
Decision
83d
Days
Class 2
Risk

K241607 is an FDA 510(k) clearance for the MyoStrain (6.0). This device is classified as a System, Nuclear Magnetic Resonance Imaging (Class II - Special Controls, product code LNH).

Submitted by Myocardial Solutions, Inc. (Morrisville, US). The FDA issued a Cleared decision on August 26, 2024, 83 days after receiving the submission on June 4, 2024.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.1000.

Submission Details

510(k) Number K241607 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 04, 2024
Decision Date August 26, 2024
Days to Decision 83 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code LNH - System, Nuclear Magnetic Resonance Imaging
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.1000

Similar Devices - LNH System, Nuclear Magnetic Resonance Imaging

All 83
S-scan Open (100001800)
K260746 · Esaote, S.P.A. · Mar 2026
Vantage Fortian/Orian 1.5T, MRT-1550, V10.0 with AiCE Reconstruction Processing Unit for MR
K253625 · Canon Medical Systems Corporation · Mar 2026
nordicAudio (1.0)
K251937 · Nordicneurolab AS · Mar 2026
Embrace Neonatal MRI System
K254277 · Aspect Imaging, Ltd. · Mar 2026
LiverMultiScan (v6.0)
K253413 · Perspectum, Ltd. · Mar 2026
Magnifico Open (100009900)
K251901 · Esaote, S.P.A. · Mar 2026